General Biotechnologies

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.

Think Bioscience

This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.

Bloom Science

This biotechnology company develops microbiome-based oral therapeutics for patients with rare neurological conditions and metabolic disorders like obesity and epilepsy.

redbiotec

This company develops proteins and genetic materials for the biopharma and food industries, including engineered bacteria for cancer and genetic disorder therapies.

BEO Therapeutics

This company develops oral microbiome therapies to treat patients with gouty arthritis and chronic kidney disease by reducing metabolic waste products.

CHAIN Biotech

This biotechnology company develops oral vaccines and microbiome therapeutics using engineered bacteria to treat solid tumour cancers and chronic diseases for pharmaceutical partners.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.

I2 Therapeutics

This company develops oral drug delivery formulations and long-acting therapies for metabolic and inflammatory diseases to improve patient adherence and treatment efficacy.